ABIONYX Pharma SA (CEREN):企業の財務・戦略的SWOT分析

◆英語タイトル:ABIONYX Pharma SA (CEREN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH140130FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ABIONYX Pharma SA (ABIONYX) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. Its therapies include CER-001 a negatively-charged lipoprotein particle that find application in atheosclerotic plaque regression; and CER-209 is a simulator of HDL receptors. The company develops a portfolio of HDL therapies including HDL mimetics for the rapid regression of atherosclerotic plaque in high-risk patients such as patients with HDL deficiency, and post-ACS patients. It also develops drugs that increase HDL for patients with low number of HDL particles to treat atherosclerosis and related metabolic diseases. ABIONYX works in partnership with other research and biotechnology companies for the development of HDL drug delivery products and technologies. The company has presence in France and the US. Cerenis is headquartered in France.

ABIONYX Pharma SA Key Recent Developments

Feb 25,2021: ABIONYX Pharma: annual results 2020
Feb 04,2021: ABIONYX Pharma provides an update on its cash position and the start of its clinical activities in Q4 2020
Oct 22,2020: ABIONYX announces its cash position and provides an activity update for the 3rd quarter 2020
Sep 10,2020: ABIONYX Pharma: 2020 Half-year results
Apr 23,2020: Gross cash position and business review for the first quarter of 2020

This comprehensive SWOT profile of ABIONYX Pharma SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ABIONYX Pharma SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

ABIONYX Pharma SA – Key Information
ABIONYX Pharma SA – Overview
ABIONYX Pharma SA – Key Employees
ABIONYX Pharma SA – Key Employee Biographies
ABIONYX Pharma SA – Key Operational Heads
ABIONYX Pharma SA – Major Products and Services
ABIONYX Pharma SA – History
ABIONYX Pharma SA – Company Statement
ABIONYX Pharma SA – Locations And Subsidiaries
ABIONYX Pharma SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

ABIONYX Pharma SA – Business Description
ABIONYX Pharma SA – Corporate Strategy
ABIONYX Pharma SA – SWOT Analysis
SWOT Analysis – Overview
ABIONYX Pharma SA – Strengths
ABIONYX Pharma SA – Weaknesses
ABIONYX Pharma SA – Opportunities
ABIONYX Pharma SA – Threats
ABIONYX Pharma SA – Key Competitors

Section 3 – Company Financial Performance Charts

ABIONYX Pharma SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

ABIONYX Pharma SA, Key Information
ABIONYX Pharma SA, Key Ratios
ABIONYX Pharma SA, Share Data
ABIONYX Pharma SA, Major Products and Services
ABIONYX Pharma SA, History
ABIONYX Pharma SA, Key Employees
ABIONYX Pharma SA, Key Employee Biographies
ABIONYX Pharma SA, Key Operational Heads
ABIONYX Pharma SA, Other Locations
ABIONYX Pharma SA, Subsidiaries
ABIONYX Pharma SA, Key Competitors
ABIONYX Pharma SA, SWOT Analysis
ABIONYX Pharma SA, Ratios based on current share price
ABIONYX Pharma SA, Annual Ratios
ABIONYX Pharma SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[ABIONYX Pharma SA (CEREN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Norfolk Southern Corporation:企業の戦略・SWOT・財務情報
    Norfolk Southern Corporation - Strategy, SWOT and Corporate Finance Report Summary Norfolk Southern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bioneer Corp (064550):医療機器:M&Aディール及び事業提携情報
    Summary Bioneer Corp (Bioneer) is a molecular diagnostic company that develops and produces molecular research and molecular diagnostic products and instruments. The company’s major molecular research products include DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and r …
  • Bryce Corporation:企業の戦略・SWOT・財務分析
    Bryce Corporation - Strategy, SWOT and Corporate Finance Report Summary Bryce Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Singapore Exchange Limited (S68):企業の財務・戦略的SWOT分析
    Singapore Exchange Limited (S68) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Aeroflot OAO:企業のM&A・事業提携・投資動向
    Aeroflot OAO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aeroflot OAO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Sage Therapeutics Inc (SAGE):企業の財務・戦略的SWOT分析
    Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Dynasil Corporation of America (DYSL):企業の財務・戦略的SWOT分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company’s products include beam splitters, bandpass filters, coatings, crystal materials, imaging detectors, diffraction gratings, tunable light sourc …
  • Mycenax Biotech Inc (4726):企業の財務・戦略的SWOT分析
    Summary Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn's Disease, …
  • The Kansai Electric Power Company Inc (9503)-エネルギー分野:企業M&A・提携分析
    Summary The Kansai Electric Power Company Inc (KEPCo) is an integrated power utility. The company produces and supplies electricity; and procures and sells natural gas. It generates electricity from natural gas, oil, nuclear, coal, hydro, wind, and solar sources. Through long, medium, and short term …
  • The Norinchukin Bank:企業の戦略・SWOT・財務分析
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Net Insight AB (NETI B):企業の財務・戦略的SWOT分析
    Net Insight AB (NETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • NuStar GP Holdings LLC (NSH):企業の財務・戦略的SWOT分析
    Summary NuStar GP Holdings LLC (NuStar) is an oil and gas company that offers transportation and logistics services to petroleum products and anhydrous ammonia. The company offers services such as terminalling and storage of petroleum products, petroleum refining and marketing, and transportation of …
  • National Research Corp (NRCIB):企業の財務・戦略的SWOT分析
    Summary National Research Corp (NRC) is a healthcare organization that provides market insight solutions. The company’s solutions include experience collection, market insights, transparency of experience data and governance. It offers market insights solutions that allow the tracking of awareness, …
  • Acona Holding AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Acona Holding AS (Acona) is an oil and gas company that offers well management and cleaning technology services. The company’s services include drilling and well technology services, exploration and production technology, field development, and oil and gas consulting services. It also provid …
  • Shop Direct Holdings Limited:企業の戦略・SWOT・財務情報
    Shop Direct Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Shop Direct Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • HomeStay Care Ltd (HSC):企業の財務・戦略的SWOT分析
    HomeStay Care Ltd (HSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Water Intelligence PLC (WATR):企業の財務・戦略的SWOT分析
    Summary Water Intelligence plc (Water Intelligence) formerly Qonnectis Plc, is a clean technology company that offers environmental and technology services. The company offers services such as finding, detecting, and remediating water leaks services. It monitors and protects water infrastructure and …
  • Itamar Medical Ltd (ITMR)-製薬・医療分野:企業M&A・提携分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that offers bio-medical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a …
  • Lagardere Travel Retail S.A.S:企業の戦略・SWOT・財務情報
    Lagardere Travel Retail S.A.S - Strategy, SWOT and Corporate Finance Report Summary Lagardere Travel Retail S.A.S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • TKH Group NV (TWEKA):企業の財務・戦略的SWOT分析
    TKH Group NV (TWEKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆